Edition:
United States

Hofseth Biocare ASA (HOFBC.OL)

HOFBC.OL on Oslo Stock Exchange

1.89NOK
7:35am EST
Change (% chg)

kr0.12 (+6.78%)
Prev Close
kr1.77
Open
kr1.78
Day's High
kr1.89
Day's Low
kr1.78
Volume
2,300
Avg. Vol
111,423
52-wk High
kr2.50
52-wk Low
kr1.12

Latest Key Developments (Source: Significant Developments)

Hofseth Biocare Q3 EBITDA loss narrows to NOK 6.3 mln
Wednesday, 15 Nov 2017 01:53am EST 

Nov 15 (Reuters) - HOFSETH BIOCARE ASA ::Q3 OPERATING REVENUE NOK ‍27.9​ MILLION VERSUS NOK 3.6 MILLION YEAR AGO.Q3 EBITDA LOSS NOK ‍6.3 ​ MILLION VERSUS LOSS NOK 41.2 MILLION YEAR AGO.‍PRODUCED 665 TONS OF FINISHED PRODUCTS DURING Q3 OF 2017, UP 10 PER CENT FROM LAST QUARTER​.  Full Article

Hofseth Biocare expects to report Q3 revenues of about NOK 28 mln​
Tuesday, 10 Oct 2017 04:18am EDT 

Oct 10 (Reuters) - HOFSETH BIOCARE ASA ::‍BASED ON PRELIMINARY FIGURES FOR Q3 2017, HOFSETH EXPECTS TO REPORT GROUP REVENUES OF ABOUT NOK 28M FOR QUARTER​.‍CASH BALANCE BY END OF Q3 WAS APPROX. NOK 30M​.  Full Article

Hofseth Biocare: Roger Hofseth new CEO in HBC
Monday, 14 Aug 2017 10:40am EDT 

Aug 14 (Reuters) - HOFSETH BIOCARE ASA ::REG-HOFSETH BIOCARE ASA: ROGER HOFSETH NEW CEO IN HBC.TOR ERIK S. ANDERSEN HAS CHOSEN TO LEAVE HIS POSITION AS CEO OF HBC.CHAIRMAN OF BOARD, ROGER HOFSETH, ENTERS POSITION AS CEO FROM TODAY'S DATE.  Full Article

Hofseth Biocare to sell and lease contracts of properties
Friday, 3 Mar 2017 05:50am EST 

Hofseth Biocare ASA : To sell and lease company's property at Midsund . HBC Berkåk as entered into an agreement for sale and lease of property at Berkåk . Says plants are sold for a joint consideration of 80 million Norwegian crowns ($9.5 million), of which 51.5 million crowns is payable for Midsund plant and 28.5 million crowns is payable for Berkåk plant . Agreements are entered into with Syvde Eiendom, a wholly owned subsidiary of major shareholder alliance Seafoods Inc . Says shall enter into a 15-year lease agreement regarding midsund property with an annual lease sum of 4,635,000 crowns .Says HBC Berkåk shall enter into a lease agreement for Berkåk property with same term and with an annual lease sum of 2,565,00 crowns.  Full Article

Hofseth Biocare Q3 EBITDA loss widens to NOK 41.2 mln
Friday, 18 Nov 2016 01:34am EST 

Hofseth Biocare : Reported on Thursday Q3 operating revenues of 3.6 million Norwegian crowns ($420,000) versus 16.6 million crowns year ago . Q3 EBITDA loss 41.2 million crowns versus loss 11.5 million crowns .Q3 operating expenses amounted to 49.2 million crowns (32.3 million crowns year ago), including inventory write-offs of 25.9 million crowns.  Full Article

Hofseth Biocare receives patent in the European Union
Wednesday, 5 Oct 2016 06:57am EDT 

Hofseth Biocare ASA :Announces grant of its European patent application no. 08861633.9 for compositions and methods for increasing iron absorption.  Full Article

Hofseth biocare announces equity issue of minimum NOK 165 mln
Monday, 29 Aug 2016 02:00am EDT 

Hofseth Biocare ASA : Announces an equity issue of minimum 165 million Norwegian crowns ($20 million) at a subscription price of 1.50 per share crown . Cash equity issue of minimum 59 million crowns towards Alliance Seafoods Inc. and certain shareholders of which Alliance Seafoods will subscribe for 50 million crowns . Buy-back of all outstanding convertible bonds by issuing new shares worth about 75.3 million crowns based on subscription price .Board will propose a subsequent offering up to 20 million crowns to limit dilutive effect of equity issue..  Full Article

Hofseth Biocare Q2 operating loss widens to NOK 47.5 million
Monday, 29 Aug 2016 02:00am EDT 

Hofseth Biocare ASA : Q2 operating revenue 8.2 million Norwegian crowns ($989,848) versus 6.4 million crowns year ago . Q2 operating loss 47.5 million crowns versus loss 19.1 million crowns year ago .Expects to recognize significant negative one-off items during q3.  Full Article

Hofseth Biocare: OmeGo patent notice of allowance in US and new study on ProGo
Tuesday, 2 Aug 2016 02:53am EDT 

Hofseth Biocare ASA : US patent office has issued a Notice of Allowance on one of HBC's key licensed-in salmon oil patent applications . Grant of this patent will allow HBC to bolster its marketing for improved heart health with a unique and proprietary mechanism of action now with patent protection in largest nutraceutical market in world .Trial shows that even small doses of ProGo will stimulate energy and vitality in normal individuals.  Full Article

Hofseth Biocare cancels subsequent offering
Thursday, 26 May 2016 07:24am EDT 

Hofseth Biocare ASA : Board of Directors decided to withdraw its proposal for subsequent offering .Says the company's existing shareholders have been able to neutralize dilutive effect of share issue, which was adopted on April 22, by buying shares in open market at price below subscription price of 2.00 Norwegian crowns per share.  Full Article

BRIEF-Hofseth Biocare Q3 EBITDA loss narrows to NOK 6.3 mln

* Q3 OPERATING REVENUE NOK ‍27.9​ MILLION VERSUS NOK 3.6 MILLION YEAR AGO